These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3328251)

  • 21. Immunostimulating properties and three-dimensional structure of two tripeptides from human and cow caseins.
    Berthou J; Migliore-Samour D; Lifchitz A; Delettré J; Floc'h F; Jollès P
    FEBS Lett; 1987 Jun; 218(1):55-8. PubMed ID: 3595863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interactions between antibiotics and immune defenses. Conclusions].
    Gialdroni Grassi G
    J Chemother; 1994 Aug; 6 Suppl 3():31-2. PubMed ID: 7861208
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancement of mouse immune system by pyrrolomycin B.
    Umezawa K; Ishizuka M; Sawa T; Takeuchie T
    J Antibiot (Tokyo); 1984 Oct; 37(10):1253-6. PubMed ID: 6501096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunomodulating action of eubiotics].
    Lopatina TK; Bliakher MS; Nikolaenko VN; Nilovskií MN; Pozhalostina LV; Rubtsov OV; Rokosueva LA; Petrova NV
    Vestn Ross Akad Med Nauk; 1997; (3):30-4. PubMed ID: 9181853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulatory activities of fluoroquinolones.
    Dalhoff A
    Infection; 2005 Dec; 33 Suppl 2():55-70. PubMed ID: 16518713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of macrolides, lincosamides and streptogramins.
    Osono T; Umezawa H
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():151-66. PubMed ID: 3932301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.
    Bosnar M; Kelnerić Z; Munić V; Eraković V; Parnham MJ
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2372-7. PubMed ID: 15917536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nonantibiotic properties of macrolides and their role in modulation of the inflammatory reaction].
    Zupanets IA; Tkachenko EM; Sakharova TS
    Eksp Klin Farmakol; 2012; 75(12):41-5. PubMed ID: 23700669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propionibacterium acnes induces an adjuvant effect in B-1 cells and affects their phagocyte differentiation via a TLR2-mediated mechanism.
    Gambero M; Teixeira D; Butin L; Ishimura ME; Mariano M; Popi AF; Longo-Maugéri IM
    Immunobiology; 2016 Sep; 221(9):1001-11. PubMed ID: 27233619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory capabilities of macrolides.
    Zalewska-Kaszubska J; Górska D
    Pharmacol Res; 2001 Dec; 44(6):451-4. PubMed ID: 11735349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapeutic agents: aspects of their activity on natural mechanisms of defense against infections.
    Fietta A; Mangiarotti P; Gialdroni Grassi G
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):325-38. PubMed ID: 6350196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic Antibiotic Use in COPD and the Potential Anti-Inflammatory Activities of Antibiotics.
    Huckle AW; Fairclough LC; Todd I
    Respir Care; 2018 May; 63(5):609-619. PubMed ID: 29463692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cholera toxin B subunit directly costimulates antigen-primed CD4+ T cells ex vivo.
    Wang M; Bregenholt S; Petersen JS
    Scand J Immunol; 2003 Sep; 58(3):342-9. PubMed ID: 12950681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.
    Leclercq R
    Clin Infect Dis; 2002 Feb; 34(4):482-92. PubMed ID: 11797175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of pH on the in vitro activity of and propensity for emergence of resistance to fluoroquinolones, macrolides, and a ketolide.
    Dalhoff A; Schubert S; Ullmann U
    Infection; 2005 Dec; 33 Suppl 2():36-43. PubMed ID: 16518710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pefloxacin and immunity: cellular uptake, potentiation of macrophage phagocytosis and intracellular bioactivity for Klebsiella pneumoniae.
    Cuffini AM; Tullio V; Fazari S; Allocco A; Carlone NA
    Int J Tissue React; 1992; 14(3):131-9. PubMed ID: 1446977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review).
    Perletti G; Skerk V; Magri V; Markotic A; Mazzoli S; Parnham MJ; Wagenlehner FM; Naber KG
    Mol Med Rep; 2011; 4(6):1035-44. PubMed ID: 21874250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibacterial and immunomodulating therapy of respiratory tract diseases].
    Sil'vestrov VP; Karaulov AV
    Ter Arkh; 1983; 55(3):3-9. PubMed ID: 6344301
    [No Abstract]   [Full Text] [Related]  

  • 40. New immunostimulating drug.
    Clin Bull; 1980; 10(2):76-7. PubMed ID: 7398038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.